Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm

Objectives: Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthly CA125 tests and annual ultrasound, with further tests prompted by an abnormal result. The study evaluated the longer-term psychological and behavioural effects of frequent ovarian screening. Methods...

Full description

Bibliographic Details
Main Authors: Brain, K, Lifford, K, Fraser, L, Rosenthal, A, Rogers, M, Lancastle, D, Phelps, C, Watson, E, Clements, A, Menon, U
Format: Journal article
Language:English
Published: 2012
_version_ 1797093875225985024
author Brain, K
Lifford, K
Fraser, L
Rosenthal, A
Rogers, M
Lancastle, D
Phelps, C
Watson, E
Clements, A
Menon, U
author_facet Brain, K
Lifford, K
Fraser, L
Rosenthal, A
Rogers, M
Lancastle, D
Phelps, C
Watson, E
Clements, A
Menon, U
author_sort Brain, K
collection OXFORD
description Objectives: Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthly CA125 tests and annual ultrasound, with further tests prompted by an abnormal result. The study evaluated the longer-term psychological and behavioural effects of frequent ovarian screening. Methods: Women completed T1 questionnaires before their first routine 4-monthly CA125 test, and T2 follow-up questionnaires one week after their result. Women with abnormal results completed a further questionnaire one week after return to routine screening (T3 primary end-point). T4 questionnaires were sent at nine months. Measures included cancer distress, general anxiety/depression, reassurance, and withdrawal from screening. Results: A total 1999 (62%) of 3224 women completed T1 questionnaires. T2 questionnaires were completed by 1384/1609 participants (86%): 1217 (89%) with normal results and 167/242 (69%) with abnormal results. T3 questionnaires were completed by 141/163 (87%) women, with 912/1173 (78%) completing T4 questionnaires. Analysis of covariance indicated that, compared to women with normal results, women with abnormal results reported moderate cancer distress (F = 27.47, p ≤.001, η2 = 0.02) one week after their abnormal result and were significantly more likely to withdraw from screening (OR = 4.38, p ≤.001). These effects were not apparent at T3 or T4. The effect of screening result on general anxiety/depression or overall reassurance was not significant. Conclusions: Women participating in frequent ovarian screening who are recalled for an abnormal result may experience transient cancer-specific distress, which may prompt reconsideration of risk management options. Health professionals and policy makers may be reassured that frequent familial ovarian screening does not cause sustained psychological harm. © 2012 Elsevier Inc. All rights reserved.
first_indexed 2024-03-07T04:06:26Z
format Journal article
id oxford-uuid:c656f57c-11b3-4e5e-b76b-6a666ca525ab
institution University of Oxford
language English
last_indexed 2024-03-07T04:06:26Z
publishDate 2012
record_format dspace
spelling oxford-uuid:c656f57c-11b3-4e5e-b76b-6a666ca525ab2022-03-27T06:37:17ZPsychological outcomes of familial ovarian cancer screening: No evidence of long-term harmJournal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:c656f57c-11b3-4e5e-b76b-6a666ca525abEnglishSymplectic Elements at Oxford2012Brain, KLifford, KFraser, LRosenthal, ARogers, MLancastle, DPhelps, CWatson, EClements, AMenon, UObjectives: Ovarian cancer screening for women at increased genetic risk in the UK involves 4-monthly CA125 tests and annual ultrasound, with further tests prompted by an abnormal result. The study evaluated the longer-term psychological and behavioural effects of frequent ovarian screening. Methods: Women completed T1 questionnaires before their first routine 4-monthly CA125 test, and T2 follow-up questionnaires one week after their result. Women with abnormal results completed a further questionnaire one week after return to routine screening (T3 primary end-point). T4 questionnaires were sent at nine months. Measures included cancer distress, general anxiety/depression, reassurance, and withdrawal from screening. Results: A total 1999 (62%) of 3224 women completed T1 questionnaires. T2 questionnaires were completed by 1384/1609 participants (86%): 1217 (89%) with normal results and 167/242 (69%) with abnormal results. T3 questionnaires were completed by 141/163 (87%) women, with 912/1173 (78%) completing T4 questionnaires. Analysis of covariance indicated that, compared to women with normal results, women with abnormal results reported moderate cancer distress (F = 27.47, p ≤.001, η2 = 0.02) one week after their abnormal result and were significantly more likely to withdraw from screening (OR = 4.38, p ≤.001). These effects were not apparent at T3 or T4. The effect of screening result on general anxiety/depression or overall reassurance was not significant. Conclusions: Women participating in frequent ovarian screening who are recalled for an abnormal result may experience transient cancer-specific distress, which may prompt reconsideration of risk management options. Health professionals and policy makers may be reassured that frequent familial ovarian screening does not cause sustained psychological harm. © 2012 Elsevier Inc. All rights reserved.
spellingShingle Brain, K
Lifford, K
Fraser, L
Rosenthal, A
Rogers, M
Lancastle, D
Phelps, C
Watson, E
Clements, A
Menon, U
Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
title Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
title_full Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
title_fullStr Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
title_full_unstemmed Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
title_short Psychological outcomes of familial ovarian cancer screening: No evidence of long-term harm
title_sort psychological outcomes of familial ovarian cancer screening no evidence of long term harm
work_keys_str_mv AT braink psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT liffordk psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT fraserl psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT rosenthala psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT rogersm psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT lancastled psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT phelpsc psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT watsone psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT clementsa psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm
AT menonu psychologicaloutcomesoffamilialovariancancerscreeningnoevidenceoflongtermharm